Kusajili – Clinical trials directory

Result of your search per sponsor: Janssen-Cilag International NV (JCI)

Woman and Man Max 99 years
Janssen-Cilag International NV (JCI) Update Il y a 4 ans

An Open-label, Randomized Study of Subcutaneous and Intravenous VELCADE® in Subjects With Previously Treated Multiple Myeloma The primary objective is to compare the overall response rate ORR (CR+PR), after 4 cycles, of subcutaneously (SC) administered VELCADE® and intravenously (IV) administered VELCADE® in patients with pr...

Country None
organs None
Specialty None

Closed trial

More information